4 unknown, 2 completed, 1 not yet recruiting. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Unknown 4, Completed 2, Not yet recruiting 1 |
Follow No-Reflow Phenomenon: new trials by email Literature Review of No-Reflow Phenomenon trials Research Report on No-Reflow Phenomenon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury - STEMI, Large Thrombus Burden | Not applicable | Not yet recruiting | Cairo University | 626 | 2024-01-01 | 2023-08-31 |
| Alpha Lipoic Acid Effect on No-Reflow Phenomenon Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI - No-Reflow Phenomenon | Not applicable | Completed | Ain Shams University | 70 | 2022-01-01 | 2024-11-05 |
| the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI) 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S - No-Reflow Phenomenon | Not applicable | Unknown | Assiut University | 120 | 2021-05-01 | 2021-04-14 |
| The EPIVER Randomized Controlled Trial Standard therapy, Epinephrine, Verapamil - ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention | Not applicable | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 104 | 2020-12-30 | 2026-06-24 |
| Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI Empagliflozin, placebo - Reperfusion Injury, Myocardial | Not applicable | Unknown | Chinese PLA General Hospital | 128 | 2018-10-01 | 2018-07-19 |
| Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method coronary angiography - Coronary Artery Disease, Coronary Artery Ectasia | Not applicable | Unknown | Ertan YETKIN | 2000 | 2016-07-01 | 2016-07-13 |
| Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI) coronary angiography - Coronary Angiography, Coronary Artery Disease | Not applicable | Unknown | Vascular and Molecular Cardiology Society | 2000 | 2016-07-01 | 2016-07-12 |
Coronary Aneurysm (2) · Coronary Artery Disease (2) · Reperfusion Injury (2) · ST Elevation Myocardial Infarction (2) · Anxiety Disorders (1) · Coronary Disease (1) · Depression (1) · Myocardial Infarction (1) · Myocardial Reperfusion Injury (1)
Ischemia (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Cardiovascular Diseases (6) · Heart Diseases (6) · Myocardial Ischemia (6) · Vascular Diseases (6) · Infarction (3) · Necrosis (3) · Aneurysm (2) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Myocardial Infarction (2) · Postoperative Complications (2) · Behavior (1)
Dietary Supplements (1) · Epinephrine (1) · Evoked Potentials, Visual (1) · Standard of Care (1) · Thioctic Acid (1) · Verapamil (1) · empagliflozin (1)
Ain Shams University (1) · Assiut University (1) · Cairo University (1) · Chinese PLA General Hospital (1) · Ertan YETKIN (1) · Tomsk National Research Medical Center of the Russian Academy of Sciences (1) · Vascular and Molecular Cardiology Society (1)
Turkey (Türkiye) (2) · Egypt (1) · Russia (1)
Ahmad Samir (1) · Ayman M Saleh, MD (1) · Lamiaa M El Wakeel, PhD (1) · Marwa Adel Ahmed, PhD (1) · Vyacheslav V Ryabov, MD, PhD (1)